Class information for:
Level 1: INTERLEUKIN 2//LYMPHOKINE ACTIVATED KILLER CELLS//RECOMBINANT INTERLEUKIN 2

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1471 2640 33.1 75%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
210 3       IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS 51916
328 2             NK CELLS//NATURAL KILLER CELLS//KIR 18140
1471 1                   INTERLEUKIN 2//LYMPHOKINE ACTIVATED KILLER CELLS//RECOMBINANT INTERLEUKIN 2 2640

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INTERLEUKIN 2 authKW 732852 18% 13% 470
2 LYMPHOKINE ACTIVATED KILLER CELLS authKW 195155 3% 26% 66
3 RECOMBINANT INTERLEUKIN 2 authKW 97077 1% 37% 23
4 LAK CELLS authKW 82803 1% 22% 33
5 JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS journal 82558 2% 12% 59
6 JOURNAL OF IMMUNOTHERAPY journal 63259 4% 6% 96
7 RENAL CELL CANCER authKW 59537 2% 9% 57
8 RENAL CELL CARCINOMA authKW 57430 7% 3% 190
9 CANCER IMMUNOLOGY IMMUNOTHERAPY journal 48426 5% 3% 135
10 RUPPERT address 46258 0% 100% 4

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 29988 55% 0% 1447
2 Immunology 8307 28% 0% 733
3 Medicine, Research & Experimental 2254 12% 0% 313
4 Urology & Nephrology 1413 7% 0% 196
5 Hematology 161 3% 0% 85
6 Pharmacology & Pharmacy 101 6% 0% 169
7 Surgery 69 5% 0% 136
8 Cell Biology 51 4% 0% 118
9 Medicine, General & Internal 31 3% 0% 91
10 Pathology 26 2% 0% 43

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RUPPERT 46258 0% 100% 4
2 UNITE ONCOL RADIOTHER IE 23129 0% 100% 2
3 SECT MELANOMA RENAL CANC IMMUNOTHER Y 17344 0% 50% 3
4 ADME TOXICOL SCREENING DEV S 11565 0% 100% 1
5 ADV BIOCHEMOTHER Y 11565 0% 100% 1
6 ANTICANC DRUGS PHARMACOL TOXICOL 11565 0% 100% 1
7 BONE MARROW TRANSPLANTAT CANC IMMUNOBIOL R 11565 0% 100% 1
8 BRODY MEDLEO JENKINS CANC 11565 0% 100% 1
9 CANC TREATMENTSURG BRANCHBLDG 10ROOM 2B47 11565 0% 100% 1
10 CLIN CHEM BIOSTAT 11565 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS 82558 2% 12% 59
2 JOURNAL OF IMMUNOTHERAPY 63259 4% 6% 96
3 CANCER IMMUNOLOGY IMMUNOTHERAPY 48426 5% 3% 135
4 CANCER BIOTHERAPY 35153 1% 18% 17
5 BIOTHERAPY 22613 1% 8% 24
6 MOLECULAR BIOTHERAPY 19530 0% 24% 7
7 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 12622 2% 3% 40
8 LYMPHOKINE AND CYTOKINE RESEARCH 5934 0% 5% 11
9 CANCER RESEARCH 5469 5% 0% 138
10 CANCER TREATMENT REPORTS 4364 1% 1% 29

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 INTERLEUKIN 2 732852 18% 13% 470 Search INTERLEUKIN+2 Search INTERLEUKIN+2
2 LYMPHOKINE ACTIVATED KILLER CELLS 195155 3% 26% 66 Search LYMPHOKINE+ACTIVATED+KILLER+CELLS Search LYMPHOKINE+ACTIVATED+KILLER+CELLS
3 RECOMBINANT INTERLEUKIN 2 97077 1% 37% 23 Search RECOMBINANT+INTERLEUKIN+2 Search RECOMBINANT+INTERLEUKIN+2
4 LAK CELLS 82803 1% 22% 33 Search LAK+CELLS Search LAK+CELLS
5 RENAL CELL CANCER 59537 2% 9% 57 Search RENAL+CELL+CANCER Search RENAL+CELL+CANCER
6 RENAL CELL CARCINOMA 57430 7% 3% 190 Search RENAL+CELL+CARCINOMA Search RENAL+CELL+CARCINOMA
7 IMMUNOTHERAPY 35140 7% 2% 197 Search IMMUNOTHERAPY Search IMMUNOTHERAPY
8 IL 2 LIPOSOMES 34694 0% 100% 3 Search IL+2+LIPOSOMES Search IL+2+LIPOSOMES
9 INTERFERON ALPHA 33865 3% 3% 87 Search INTERFERON+ALPHA Search INTERFERON+ALPHA
10 ADVANCED RENAL CANCER 26430 0% 57% 4 Search ADVANCED+RENAL+CANCER Search ADVANCED+RENAL+CANCER

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 WHITTINGTON, R , FAULDS, D , (1993) INTERLEUKIN-2 - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN PATIENTS WITH CANCER.DRUGS. VOL. 46. ISSUE 3. P. 446-514 266 58% 183
2 VLASVELD, LT , RANKIN, EM , (1994) RECOMBINANT INTERLEUKIN-2 IN CANCER - BASIC AND CLINICAL ASPECTS.CANCER TREATMENT REVIEWS. VOL. 20. ISSUE 3. P. 275-311 210 66% 9
3 BUKOWSKI, RM , (1997) NATURAL HISTORY AND THERAPY OF METASTATIC RENAL CELL CARCINOMA - THE ROLE OF INTERLEUKIN-2.CANCER. VOL. 80. ISSUE 7. P. 1198-1220 127 69% 201
4 BAATEN, G , VOOGD, AC , WAGSTAFF, J , (2004) A SYSTEMATIC REVIEW OF THE RELATION BETWEEN INTERLEUKIN-2 SCHEDULE AND OUTCOME IN PATIENTS WITH METASTATIC RENAL CELL CANCER.EUROPEAN JOURNAL OF CANCER. VOL. 40. ISSUE 8. P. 1127-1144 86 88% 11
5 ELIAS, L , HUNT, WC , (2001) A LITERATURE ANALYSIS OF PROGNOSTIC FACTORS FOR RESPONSE AND QUALITY OF RESPONSE OF PATIENTS WITH RENAL CELL CARCINOMA TO INTERLEUKIN-2-BASED THERAPY.ONCOLOGY. VOL. 61. ISSUE 2. P. 91 -101 86 83% 8
6 MANSECK, A , WIRTH, M , (1993) IMMUNE THERAPY OF ADVANCED RENAL-CELL CARCINOMA.UROLOGE-AUSGABE A. VOL. 32. ISSUE 5. P. 360-373 99 91% 2
7 HEINZER, H , HULAND, E , HULAND, H , (2001) SYSTEMIC CHEMOTHERAPY AND CHEMOIMMUNOTHERAPY FOR METASTATIC RENAL CELL CANCER.WORLD JOURNAL OF UROLOGY. VOL. 19. ISSUE 2. P. 111 -119 78 80% 17
8 BRUTON, JK , KOELLER, JM , (1994) RECOMBINANT INTERLEUKIN-2.PHARMACOTHERAPY. VOL. 14. ISSUE 6. P. 635-656 98 77% 22
9 WIRTH, MP , (1993) IMMUNOTHERAPY FOR METASTATIC RENAL-CELL CARCINOMA.UROLOGIC CLINICS OF NORTH AMERICA. VOL. 20. ISSUE 2. P. 283-295 72 90% 129
10 JEAL, W , GOA, KL , (1997) ALDESLEUKIN (RECOMBINANT INTERLEUKIN-2) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN PATIENTS WITH RENAL CELL CARCINOMA.BIODRUGS. VOL. 7. ISSUE 4. P. 285-317 76 78% 13

Classes with closest relation at Level 1


Rank Class id link
1 23373 IMMUNOL BIOTHER Y PROGRAM//INTERLEUKIN 2//MHC NONRESTRICTED CYTOTOXICITY
2 31046 A NK CELLS//T LAK CELLS//ACTIVATED NATURAL KILLER CELLS
3 7508 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//TIL
4 36334 ARTMENT PUBL HLTH GEN PRACTICE//CLIN OCCUPAT ENVIRONM MED COPENHAGEN//D13S153
5 16143 SECT PHARMACOL MED ONCOL//INTERDIPARTIMENTALE EPIDEMIOL//NIKAIA GEN HOSP
6 28171 IMMUNE BASED THERAPY//AIDS MED ONCOL//CLIN MOL RETROVIROL SECT
7 26121 CANCER IMMUNODEFICIENCY//WHOLE BLOOD CELL CULTURES//AZ OSP IST OSPITALIERI VERONA
8 27803 MHC AF//BL6 MELANOMA//F10 M3 MURINE MELANOMA CELLS
9 1228 CELLULAR IMMUNOLOGY//IMMUNOLOGY//JOURNAL OF IMMUNOLOGY
10 6326 METASTATIC MELANOMA//BIOCHEMOTHERAPY//DACARBAZINE

Go to start page